Cargando…
Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517049/ https://www.ncbi.nlm.nih.gov/pubmed/34648110 http://dx.doi.org/10.1186/s43141-021-00265-5 |
_version_ | 1784583927115022336 |
---|---|
author | Mollaev, Murad Zabolotskii, Artur Gorokhovets, Neonila Nikolskaya, Elena Sokol, Maria Tsedilin, Andrey Mollaeva, Mariia Chirkina, Margarita Kuvaev, Timofey Pshenichnikova, Anna Yabbarov, Nikita |
author_facet | Mollaev, Murad Zabolotskii, Artur Gorokhovets, Neonila Nikolskaya, Elena Sokol, Maria Tsedilin, Andrey Mollaeva, Mariia Chirkina, Margarita Kuvaev, Timofey Pshenichnikova, Anna Yabbarov, Nikita |
author_sort | Mollaev, Murad |
collection | PubMed |
description | BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic stability in E. coli due to the inclusion of body formation, which is sequence specific. Thereby, the peptide itself may serve as a fusion partner and one may produce more than one mole of the desired product per mole of fusion protein. This paper proposes a method for multimeric production of a human alpha-fetoprotein fragment with optimized multimer design and processing. This fragment may further find its application in the cytotoxic drug delivery field or as an inhibitor of endogenous alpha-fetoprotein. RESULTS: Multimerization of the extended alpha-fetoprotein receptor-binding peptide improved its stability in E. coli, and pentamer was found to be the largest stable with the highest expression level. As high as 10 aspartate-proline bonds used to separate peptide repeats were easily hydrolyzed in optimized formic acid-based conditions with 100% multimer conversion. The major product was represented by unaltered functional alpha-fetoprotein fragment while most side-products were its formyl-Pro, formyl-Tyr, and formyl-Lys derivatives. Single-step semi-preparative RP-HPLC was enough to separate unaltered peptide from the hydrolysis mixture. CONCLUSIONS: A recombinant peptide derived from human alpha-fetoprotein can be produced via multimerization with subsequent formic acid hydrolysis and RP-HPLC purification. The reported procedure is characterized by the lower reagent cost in comparison with enzymatic hydrolysis of peptide fusions and solid-phase synthesis. This method may be adopted for different peptide expression, especially with low amino and hydroxy side chain content. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00265-5. |
format | Online Article Text |
id | pubmed-8517049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85170492021-10-27 Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli Mollaev, Murad Zabolotskii, Artur Gorokhovets, Neonila Nikolskaya, Elena Sokol, Maria Tsedilin, Andrey Mollaeva, Mariia Chirkina, Margarita Kuvaev, Timofey Pshenichnikova, Anna Yabbarov, Nikita J Genet Eng Biotechnol Research BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic stability in E. coli due to the inclusion of body formation, which is sequence specific. Thereby, the peptide itself may serve as a fusion partner and one may produce more than one mole of the desired product per mole of fusion protein. This paper proposes a method for multimeric production of a human alpha-fetoprotein fragment with optimized multimer design and processing. This fragment may further find its application in the cytotoxic drug delivery field or as an inhibitor of endogenous alpha-fetoprotein. RESULTS: Multimerization of the extended alpha-fetoprotein receptor-binding peptide improved its stability in E. coli, and pentamer was found to be the largest stable with the highest expression level. As high as 10 aspartate-proline bonds used to separate peptide repeats were easily hydrolyzed in optimized formic acid-based conditions with 100% multimer conversion. The major product was represented by unaltered functional alpha-fetoprotein fragment while most side-products were its formyl-Pro, formyl-Tyr, and formyl-Lys derivatives. Single-step semi-preparative RP-HPLC was enough to separate unaltered peptide from the hydrolysis mixture. CONCLUSIONS: A recombinant peptide derived from human alpha-fetoprotein can be produced via multimerization with subsequent formic acid hydrolysis and RP-HPLC purification. The reported procedure is characterized by the lower reagent cost in comparison with enzymatic hydrolysis of peptide fusions and solid-phase synthesis. This method may be adopted for different peptide expression, especially with low amino and hydroxy side chain content. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00265-5. Springer Berlin Heidelberg 2021-10-14 /pmc/articles/PMC8517049/ /pubmed/34648110 http://dx.doi.org/10.1186/s43141-021-00265-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Mollaev, Murad Zabolotskii, Artur Gorokhovets, Neonila Nikolskaya, Elena Sokol, Maria Tsedilin, Andrey Mollaeva, Mariia Chirkina, Margarita Kuvaev, Timofey Pshenichnikova, Anna Yabbarov, Nikita Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title | Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title_full | Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title_fullStr | Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title_full_unstemmed | Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title_short | Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli |
title_sort | expression of acid cleavable asp-pro linked multimeric afp peptide in e. coli |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517049/ https://www.ncbi.nlm.nih.gov/pubmed/34648110 http://dx.doi.org/10.1186/s43141-021-00265-5 |
work_keys_str_mv | AT mollaevmurad expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT zabolotskiiartur expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT gorokhovetsneonila expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT nikolskayaelena expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT sokolmaria expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT tsedilinandrey expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT mollaevamariia expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT chirkinamargarita expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT kuvaevtimofey expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT pshenichnikovaanna expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli AT yabbarovnikita expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli |